Skip links

Zantac

Were you diagnosed with cancer after years of taking Zantac?

For million of Americans who experienced heartburn, over-the-counter and prescription Zantac provided daily relief for the condition. In late 2019, independent testing revealed high levels of a carcinogen called NDMA, which set off a chain reaction of recalls. Now, those who were diagnosed with cancer after years of taking Zantac may be entitled to compensation.

Zantac (ranitidine) is a heartburn medication called a histamine-2 blocker, or H2 blocker. It works to both relieve and prevent heartburn and was a go-to medication for millions of people suffering from heartburn. In September 2019, the FDA announced that tests had found unacceptable levels of NDMA, a known carcinogen, in some generic forms of Zantac. By October 2019, some pharmacies were pulling all forms of generic ranitidine from shelves, and in April 2020, the FDA issued a recall for all ranitidine and Zantac products. The FDA noted that the NDMA in Zantac and ranitidine increased over time when stored in less than optimal conditions. 

If you or a family member took Zantac and was later diagnosed with stomach, esophageal or another form of cancer, you better call Jim at James F. Humphreys & Associates, L.C. Call us at 304-303-5510, or fill out this online contact form, and one of our team members will get back to you as soon as possible.

Call Now: 304-303-5510

Email: [email protected]